Detection rates for benign and malignant diagnoses on breast cancer screening with digital breast tomosynthesis in a Statewide Mammography Registry Study
American Journal of Roentgenology Mar 01, 2019
Fujii MH, et al. - By analyzing observational data from the Vermont Breast Cancer Surveillance System, researchers ascertained if detection rates of specific benign and malignant diagnoses are different for breast cancer screening with digital breast tomosynthesis (DBT) vs full-field digital mammography (FFDM) alone. For this investigation, they performed 86,349 DBT screening examinations and 97,378 FFDM screening examinations at eight radiology facilities in Vermont that adopted DBT screening from 2012–2016. Findings suggested that breast cancer screening with DBT has a lower recall rate compared to FFDM, while finding a comparable distribution of benign and malignant diagnoses.
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries